Regeneron Pharmaceuticals reported $1.12B in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agenus AGEN:US $ -50.6M 17M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Alimera Sciences ALIM:US $ -3.1M 2.86M
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
Astellas Pharma 4503:JP Y 31679M 42195M
Biogen BIIB:US $ 874.8M 28.6M
Biomarin Pharmaceutical BMRN:US $ 34.85M 8.66M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Intercept Pharmaceuticals ICPT:US $ -20.32M 3.04M
IONIS PHARMACEUT IONS:US $ -64M 289M
Kyowa Hakko Kirin 4151:JP Y 24763M 6047M
Neurocrine Biosciences NBIX:US $ -23.3M 44.7M
Novartis NOVN:VX SF 4129M 217M
Novartis NVS:US $ 4129M 217M
Ophthotech OPHT:US $ -49.26M 14.73M
Sarepta Therapeutics SRPT:US $ -228.09M 123.95M
Teva Pharmaceutical TEVA:IT -1160000000 189M
Ultragenyx Pharmaceutical RARE:US $ -157.86M 6.1M
United Therapeutics UTHR:US $ 150.6M 158.1M